← Leaderboards
Christopher Murray
Galen Biotechnologies, Llc
$425,667
Attributed
$425,667
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $361.4K · FY2014–15$500K$375K$250K$125K$0
'14
'15
Funding mix
By agency
NIH$425,667 · 2
By mechanism
R43$257,254 · 1
N43$168,413 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSiteDesignProtein BiosynthesisCellsProteinsProtein Protein InteractionTechnologyAntineoplastic AgentsBiologicalAffectAlpha HelixGeneticChemical ReactionBiochemicalBinding (Molecular Function)AminoacylationCopperCycloadditionBcl2 GeneDrug DesignDrug DevelopmentDrug DiscoveryAmino Acids